• Accelerating Research

  • Working with National Leprosy Programmes

  • Increasing Advocacy and Resource Mobilization

Introducing the Partnership

The Global Partnership for Zero Leprosy is a coalition of groups committed to ending leprosy, also known as Hansen’s disease. The partnership includes the Novartis Foundation, the World Health Organization (WHO, as an observer), the International Federation of Anti-Leprosy Associations (ILEP), the Sasakawa Health Foundation and the International Association for Integration, Dignity and Economic Advancement (IDEA). It also includes the national leprosy programmes of Brazil, Ghana, and India, the International Leprosy Association, scientific organizations and the academic community. The secretariat for the partnership is located at the Task Force for Global Health.

Membership is open to all organizations and individuals who are committed to zero leprosy and that support the principles, objectives, and activities of the Global Partnership for Zero Leprosy. Learn more.

Photo Credit: LEPRA

Why Now?

Since the introduction of effective multi-drug therapy (MDT) 30 years ago, the reported prevalence of leprosy has been reduced by 99%. However, the number of newly diagnosed leprosy patients has remained above 200,000 per year for the last decade, including thousands of children.

New scientific advances are changing the way we approach leprosy and may provide innovative ways to fully interrupt transmission of the disease. Recent scientific breakthroughs include improved diagnostic methods, more effective ways to prevent the spread of infections, and new ways of treating people at greatest risk.

Along with these innovations, achieving zero leprosy requires a strong global alignment behind a common vision. The leprosy community feels a renewed sense of urgency to accelerate progress through collaboration. The Global Partnership for Zero Leprosy will build on and strengthen existing collaborative networks to support leprosy programs as they adopt new tools and approaches.

Action Framework

View our upcoming and long-term milestones towards zero leprosy. Learn more.

Download PDF

Featured Resource

  • Advice about leprosy and COVID-19

    Advice about leprosy and COVID-19 from the WHO Global Leprosy Programme, ILEP, and GPZL. Includes guidance on diagnosis and clinical management of leprosy patients, public health aspects of leprosy in the COVID-19 pandemic, and services for persons living with disabilities and/or psychosocial consequences of leprosy.

    ENG FR
    Updated: 10/04/2020
  • See all resources ›